课题基金 / 基金详情

Determinants of immune response following COVID-19 natural infection and vaccination in elderly residents of UK long term care home facilities

Determinants of immune response following COVID-19 natural infection and vaccination in elderly residents of UK long term care home facilities
英国长期护理院设施老年居民 COVID-19 自然感染和疫苗接种后免疫反应的决定因素
批准号:
2738854
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Age and frailty are major determinants of outcome following COVID-19. Over 18 months our research team has acted as the hub for immunological analysis of immune responses in staff and residents of long-term care facilities (Care Homes) across the UK. This VIVALDI consortium has now acquired >15,000 blood samples which are housed within Professor Moss's research group at Birmingham.We propose a PhD training opportunity to assess the determinants of immune response in older people. This is an iCASE collaboration between University of Birmingham and The Binding Site company. This is important as immune senescence and inflammatory frailty limit the efficacy of protective immunity in older people and our aim is to identify underlying mechanisms and potential therapeutic mechanisms.The work will have five work packages.(1) Analysis of serological and cellular responses to viral proteins(2) Determination of how nutritional factors impact on immune responses(3) Assessment of inflammatory profile using novel mass spectrometry(4) Analysis of plasma cell turnover using s-BCMA assay(5) Bioinformatic analysis of these world-leading datasetsThis collaboration combines world-leading teams in academic immunology and commercial expertise in development of immune assays. The outcomes will impact on patient outcome and provide an outstanding training opportunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
声致离子电流促进小胶质细胞M2极化阻断再生神经瘢痕退变免疫机制
  • 批准号:
    82371973
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    孙迪
  • 依托单位:
转运蛋白RCP调控巨噬细胞脂肪酸氧化参与系统性红斑狼疮发病的机制研究
  • 批准号:
    82371798
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    叶俊娜
  • 依托单位:
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
  • 批准号:
    82371141
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈颖
  • 依托单位:
CD27-CD28-CD8+T细胞调控儿童肝脏移植免疫耐受形成的作用和机制
  • 批准号:
    82371791
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    刘永波
  • 依托单位: